Hui Xing
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 7
- Oncology top 10%
- Cancer-related Molecular Pathways 7
- Cancer Cells and Metastasis 3
- Molecular Biology top 10%
- Cell death mechanisms and regulation 7
- RNA modifications and cancer 7
- PI3K/AKT/mTOR signaling in cancer 5
- Circular RNAs in diseases 4
- Reproductive Medicine top 10%
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy 5
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Hui Xing
46 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 387
- Oncology 343
- Molecular Biology 768
- Reproductive Medicine 82
- Pathology and Forensic Medicine 116
Countries citing papers authored by Hui Xing
This map shows the geographic impact of Hui Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Xing more than expected).
Fields of papers citing papers by Hui Xing
This network shows the impact of papers produced by Hui Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Xing. The network helps show where Hui Xing may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2022 | 6 | |
| 8 | 2018 | 20 | |
| 9 | 2018 | 60 | |
| 10 | 2018 | 28 | |
| 11 | 2015 | 17 | |
| 12 | 2015 | 52 | |
| 13 | 2014 | 10 | |
| 14 | Ozone injection for the treatment of lumbar disc herniation: a therapeutic analysis of 104 cases | 2010 | 1 |
| 15 | 2008 | 40 | |
| 16 | 2008 | 21 | |
| 17 | 2007 | 25 | |
| 18 | 2005 | 38 | |
| 19 | 2005 | 34 | |
| 20 | 2005 | 38 |
About Hui Xing
Hui Xing is a scholar working on Cancer Research, Hepatology and Oncology, having authored 54 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (7 papers), Cancer-related molecular mechanisms research (7 papers), Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer Mechanisms and Therapy (5 papers), Circular RNAs in diseases (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Cancer Research (387 citations), Oncology (343 citations) and Molecular Biology (768 citations). Hui Xing has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Ding Ma, Danhui Weng, Jianfeng Zhou, Xiaokui Yang, Shixuan Wang, Yunping Lu, Gang Xu, Jinting Zhou, Xiaomin Qin and Gang Chen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.